Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Capsaicin palmitate is a synthetic ester formed from capsaicin and palmitic acid. It is designed as a topical analgesic for the relief of pain, particularly osteoarthritic and neuropathic pain, in a formulation that aims to reduce the burning sensation typically associated with standard capsaicin products. Upon topical administration, capsaicin palmitate is absorbed into the skin and enzymatically hydrolyzed to release free capsaicin. The released capsaicin acts primarily by activating the transient receptor potential vanilloid 1 (TRPV1) receptor—a nonselective cation channel highly permeable to calcium—on nociceptive nerve fibers. This activation leads to an initial excitation followed by desensitization or "defunctionalization" of these sensory neurons, resulting in reduced transmission of pain signals. Capsaicin also depletes substance P from sensory nerve endings and can block synaptic transmission in the spinal cord dorsal horn[5]. Capsaicin palmitate has been considered for compounding into creams or gels at concentrations delivering 1.5%–3% free capsaicin[5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on capsaicin palmitate.